Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile
Mattias Mandorfer

@mattiasmandorf1

Head of the Vienna Hepatic Hemodynamic Lab; interested in known unknowns & unknown unknowns.

ID: 1285644586359099394

calendar_today21-07-2020 18:35:37

513 Tweet

1,1K Followers

937 Following

Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

Conversation with the Customs employee at the airport when entering the U.S. for a 1-day meeting: When is your flight back? - Tomorrow. - So they pay you well. - No, I'm in academia. - Oh, so they own you. 😋

Rohit Loomba (@drloomba) 's Twitter Profile Photo

It was a pleasure to work alongside ⁦American Gastroenterological Association (AGA)⁩ headquarters in Bethesda & collaborate with ⁦AASLD⁩ ⁦EASLnews⁩ to develop a consensus paper on Alpha-1 Anti-trypsin def liver disease detection and clinical trials endpoints 🙏 to our entire panel!

It was a pleasure to work alongside ⁦<a href="/AmerGastroAssn/">American Gastroenterological Association (AGA)</a>⁩ headquarters in Bethesda &amp; collaborate with ⁦<a href="/AASLDtweets/">AASLD</a>⁩ ⁦<a href="/EASLnews/">EASLnews</a>⁩ to develop a consensus paper on Alpha-1 Anti-trypsin def liver disease detection and clinical trials endpoints 🙏 to our entire panel!
MOTION Vienna (@crgmotion) 's Twitter Profile Photo

#twitterliver #xliver#NIT #HVPG #ClinicalTrial #ACLD #PSVD #PortalHypertension Fans !! 👏👋 Introducing MOTION WP 4 & 5 focusing on #HVPG responses & NIT models.... 📷More info in the graphic 📷

#twitterliver #xliver#NIT #HVPG #ClinicalTrial #ACLD #PSVD  #PortalHypertension Fans !! 👏👋

Introducing MOTION WP 4 &amp; 5 focusing on #HVPG responses &amp; NIT models....

📷More info  in the graphic  📷
Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

Have you ever screened 25 patients for a single trial and randomized nearly as many? Vienna Hepatic Hemodynamic Lab advancing drug development for portal hypertension. Eager to see results ... #LiverTwitter The Baveno Cooperation: an EASL Consortium

Have you ever screened 25 patients for a single trial and randomized nearly as many?

Vienna Hepatic Hemodynamic Lab advancing drug development for portal hypertension. Eager to see results ...

#LiverTwitter <a href="/BavenoCoop/">The Baveno Cooperation: an EASL Consortium</a>
MOTION Vienna (@crgmotion) 's Twitter Profile Photo

"#twitterliver 👋#PortalHypertension Fans !! Introducing MOTION WP 4 by Mattias Mandorfer - Comparing #HVPG responses of our medication within our clinical trials to NSBBS... 🌐More info in the video below 📷🔽

Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

‼️Following first hepatic decompensation, patients with severe #AATD have a higher risk of complications vs. other aetiologies 👉Early listing for liver transplantation. #LiverTwitter 🔗doi.org/10.1016/j.jhep… Alpha-1 Foundation JHEP Reports

‼️Following first hepatic decompensation, patients with severe #AATD have a higher risk of complications vs. other aetiologies
👉Early listing for liver transplantation. #LiverTwitter

🔗doi.org/10.1016/j.jhep…

<a href="/AlphaFriend/">Alpha-1 Foundation</a> <a href="/JHEP_Reports/">JHEP Reports</a>
JHEP Reports (@jhep_reports) 's Twitter Profile Photo

🟪NEW Article in press❕ Severe alpha-1 antitrypsin deficiency shows a higher risk of complications after first decompensation compared to other aetiologies of #cirrhosis☆ 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #LiverTwitter

🟪NEW Article in press❕

Severe alpha-1 antitrypsin deficiency shows a higher risk of complications after first decompensation compared to other aetiologies of #cirrhosis☆ 

🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter
The Baveno Cooperation: an EASL Consortium (@bavenocoop) 's Twitter Profile Photo

🚨Missed it or want to dive deeper into the Baveno VIII Pre-Symposium Webinar: Designing Clinical Studies in Advanced Chronic Liver Disease? 📺It’s now available on demand at bavenocoop.net — members only. 🫂Membership is free You’re so welcome 😉

🚨Missed it or want to dive deeper into the Baveno VIII Pre-Symposium Webinar: Designing Clinical Studies in Advanced Chronic Liver Disease?

📺It’s now available on demand at bavenocoop.net — members only.

🫂Membership is free

You’re so welcome 😉
EASLnews (@easlnews) 's Twitter Profile Photo

🚨 Important Update 🚨 A new version of the EASL Guidelines App is now available! To access the latest features, please delete the old version and reinstall the app from your app store. 🆕 What’s new? ✅ 24 new calculators ✅ Access to EASL policy statements & policy dialogues

🚨 Important Update 🚨
A new version of the EASL Guidelines App is now available!

To access the latest features, please delete the old version and reinstall the app from your app store.

🆕 What’s new?
✅ 24 new calculators
✅ Access to EASL policy statements &amp; policy dialogues
Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

Thirteen years ago when I was still an M.D. student, I was invited for my first oral presentation at an EASLnews event. 🙏 to EASL Education for inspiration, education & support throughout this journey as well as to my mentors & friends! The Baveno Cooperation: an EASL Consortium #LiverTwitter

The Baveno Cooperation: an EASL Consortium (@bavenocoop) 's Twitter Profile Photo

Great session by Mattias Mandorfer & Elton Dajti on latest updates in managing CSPH with NITs at #EASL2025 👏 🧠 From definitions & implications of cACLD/CSPH 📚 To NIT-based algorithms in guidelines 📈 And the role of SSM in clinical practice

Great session by <a href="/MattiasMandorf1/">Mattias Mandorfer</a> &amp; <a href="/EltonDajti/">Elton Dajti</a> on latest updates in managing CSPH with NITs at #EASL2025 👏

🧠 From definitions &amp; implications of cACLD/CSPH
📚 To NIT-based algorithms in guidelines
📈 And the role of SSM in clinical practice
EASLnews (@easlnews) 's Twitter Profile Photo

The authors of today’s #readoftheweek📚 explore how TIPS leads to a sustained reduction of SI and bacterial translocation in patients with decompensated cirrhosis. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏Lukas Hartl Anja Tiede Nina Dominik

The authors of today’s #readoftheweek📚 explore how TIPS leads to a sustained reduction of SI and bacterial translocation in patients with decompensated cirrhosis.

Read here this <a href="/JHEP_Reports/">JHEP Reports</a> article: jhep-reports.eu/article/S2589-…

🙏<a href="/hartl_md/">Lukas Hartl</a> <a href="/tiede_anja/">Anja Tiede</a> <a href="/ninadominik/">Nina Dominik</a>